Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Background. Public Health England has reported a decrease of up to 20.8% in new diagnoses of external genital warts (GWs) among women aged <19 years since the national vaccination program with the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine began in 2008. A post hoc analysis of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Szarewski, Anne, Skinner, S. Rachel, Garland, Suzanne M., Romanowski, Barbara, Schwarz, Tino F., Apter, Dan, Chow, Song-Nan, Paavonen, Jorma, Del Rosario-Raymundo, M. Rowena, Teixeira, Julio C., De Carvalho, Newton S., Castro-Sanchez, Maria, Castellsagué, Xavier, Poppe, Willy A. J., De Sutter, Philippe, Huh, Warner, Chatterjee, Archana, Tjalma, Wiebren A., Ackerman, Ronald T., Martens, Mark, Papp, Kim A., Bajo-Arenas, Jose, Harper, Diane M., Torné, Aureli, David, Marie-Pierre, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789574/
https://www.ncbi.nlm.nih.gov/pubmed/24092907
http://dx.doi.org/10.1093/infdis/jit360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789574/
https://www.ncbi.nlm.nih.gov/pubmed/24092907
http://dx.doi.org/10.1093/infdis/jit360

Ejemplares similares